Recurrence of breast cancer metastases in the brain was low among women who received an experimental drug combination in a phase I clinical trial.
January 2023. Full story at National Cancer Institute.
Recurrence of breast cancer metastases in the brain was low among women who received an experimental drug combination in a phase I clinical trial.
January 2023. Full story at National Cancer Institute.